Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development
  • National Cancer Center
  • AstraZeneca
  • Pfizer Japan
  • Lilly
  • MSD
  • Boehringer Ingelheim
  • Takeda Pharmaceutical Company
  • Chugai Pharmaceutical
  • Taiho Pharmaceutical
  • Ono Pharmaceutical
  • GlaxoSmithKline
  • Shionogi
  • Novartis Pharma
  • AstraZeneca
  • Pfizer Japan
  • Lilly
  • Chugai Pharmaceutical
  • Ono Pharmaceutical Co., Ltd.
  • Takeda Pharmaceutical Company
  • Taiho Pharmaceutical
  • MSD

This publication has 30 references indexed in Scilit: